Free Trial

Labcorp (LH) Stock Price, News & Analysis

Labcorp logo
$249.24 -4.39 (-1.73%)
Closing price 03:58 PM Eastern
Extended Trading
$249.60 +0.36 (+0.14%)
As of 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Labcorp Stock (NYSE:LH)

Key Stats

Today's Range
$247.63
$252.90
50-Day Range
$241.26
$264.18
52-Week Range
$205.95
$265.72
Volume
1.14 million shs
Average Volume
647,891 shs
Market Capitalization
$20.86 billion
P/E Ratio
28.81
Dividend Yield
1.16%
Price Target
$276.38
Consensus Rating
Moderate Buy

Company Overview

Labcorp Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

LH MarketRank™: 

Labcorp scored higher than 94% of companies evaluated by MarketBeat, and ranked 52nd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Labcorp has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 9 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Labcorp has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Labcorp's stock forecast and price target.
  • Earnings Growth

    Earnings for Labcorp are expected to grow by 9.56% in the coming year, from $16.01 to $17.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Labcorp is 28.81, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.90.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Labcorp is 28.81, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.72.

  • Price to Earnings Growth Ratio

    Labcorp has a PEG Ratio of 1.61. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Labcorp has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Labcorp's valuation and earnings.
  • Percentage of Shares Shorted

    4.27% of the float of Labcorp has been sold short.
  • Short Interest Ratio / Days to Cover

    Labcorp has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in Labcorp has recently increased by 3.49%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Labcorp pays a meaningful dividend of 1.14%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Labcorp does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Labcorp is 33.29%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Labcorp will have a dividend payout ratio of 16.42% next year. This indicates that Labcorp will be able to sustain or increase its dividend.

  • Read more about Labcorp's dividend.
  • Percentage of Shares Shorted

    4.27% of the float of Labcorp has been sold short.
  • Short Interest Ratio / Days to Cover

    Labcorp has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in Labcorp has recently increased by 3.49%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Labcorp has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 40 news articles for Labcorp this week, compared to 14 articles on an average week.
  • Search Interest

    3 people have searched for LH on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Labcorp to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Labcorp insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,928,714.00 in company stock.

  • Percentage Held by Insiders

    Only 0.84% of the stock of Labcorp is held by insiders.

  • Percentage Held by Institutions

    95.94% of the stock of Labcorp is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Labcorp's insider trading history.
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Labcorp and its competitors with MarketBeat's FREE daily newsletter.

LH Stock News Headlines

Leerink Partners Keeps Their Buy Rating on Labcorp Holdings (LH)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Labcorp Declares Quarterly Dividend
See More Headlines

LH Stock Analysis - Frequently Asked Questions

Labcorp's stock was trading at $229.32 at the beginning of 2025. Since then, LH stock has increased by 8.7% and is now trading at $249.2430.

Labcorp Holdings Inc. (NYSE:LH) posted its quarterly earnings results on Tuesday, April, 29th. The medical research company reported $3.84 EPS for the quarter, topping the consensus estimate of $3.73 by $0.11. The firm's revenue was up 5.3% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Labcorp: Clinical Outreach Laboratory Services, Personal Genome Diagnostics Inc., Toxikon Corporation, Myriad Autoimmune’s Vectra Testing Business, Ovia Health, Visiun, Envigo's nonclinical contract research services business, and more.

Top institutional investors of Labcorp include Assenagon Asset Management S.A. (0.14%), Wedge Capital Management L L P NC (0.14%), Busey Bank (0.07%) and NorthCrest Asset Manangement LLC (0.05%). Insiders that own company stock include Adam H Schechter, Glenn A Eisenberg, Brian J Caveney, Lance Berberian, Paul R Kirchgraber, Kerrii B Anderson, Dwight Gary Gilliland, Amy B Summy, Mark S Schroeder, Jonathan P Divincenzo, Der Vaart Sandra D Van and Peter J Wilkinson.
View institutional ownership trends
.

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Labcorp investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
4/29/2025
Record date for 6/11 Dividend
5/29/2025
Dividend Payable
6/11/2025
Today
7/11/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Health Care Services
Current Symbol
NYSE:LH
Previous Symbol
NYSE:LH?
CIK
920148
Employees
70,000
Year Founded
1995

Price Target and Rating

High Price Target
$300.00
Low Price Target
$230.00
Potential Upside/Downside
+11.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$8.65
Trailing P/E Ratio
28.74
Forward P/E Ratio
15.53
P/E Growth
1.64
Net Income
$746 million
Net Margins
5.55%
Pretax Margin
7.11%
Return on Equity
15.27%
Return on Assets
6.97%

Debt

Debt-to-Equity Ratio
0.68
Current Ratio
1.84
Quick Ratio
1.60

Sales & Book Value

Annual Sales
$13.01 billion
Price / Sales
1.60
Cash Flow
$21.51 per share
Price / Cash Flow
11.56
Book Value
$96.27 per share
Price / Book
2.58

Miscellaneous

Outstanding Shares
83,700,000
Free Float
82,997,000
Market Cap
$20.81 billion
Optionable
Optionable
Beta
0.82

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:LH) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners